デフォルト表紙
市場調査レポート
商品コード
1272629

ダーマルフィラーの世界市場の予測(~2030年)

Global Dermal Fillers Market Forecast to 2030

出版日: | 発行: Market Research Future | ページ情報: 英文 78 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.49円
ダーマルフィラーの世界市場の予測(~2030年)
出版日: 2023年05月10日
発行: Market Research Future
ページ情報: 英文 78 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のダーマルフィラー市場は、美容整形手術の人気の向上が、予測期間における市場成長の主な促進要因となる見込みです。評価期間中、男女ともに顔の手術の人気が高まっていることが、市場成長に大きな影響を与えると予測されています。

当レポートでは、世界のダーマルフィラー市場について調査分析し、市場力学、地域とセグメントの分析、企業プロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場のイントロダクション

第3章 調査手法

第4章 市場力学

  • 概要
  • 促進要因
    • 世界的に高まるフェイシャルエステの需要
    • 形成外科医が行う美容処置件数の増加
    • 美容整形手術に代わる費用対効果の高い代替手段
  • 抑制要因
    • ダーマルフィラーに関連する副作用
    • ダーマルフィラーの闇市場と未登録医師の影響
  • 機会
    • 臨床試験数の増加
    • 低侵襲手術に対する需要の高まり

第5章 市場要因の分析

  • ポーターのファイブフォース分析
  • バリューチェーン分析
    • 研究開発
    • 美容商品の製造工程
    • マーケティングと流通

第6章 ダーマルフィラー市場:タイプ別

  • 概要
  • ヒアルロン酸
  • ポリマー、粒子
  • カルシウムヒドロキシアパタイト
  • コラーゲン

第7章 ダーマルフィラー市場:ブランド別

  • 概要
  • ジュビダーム
  • レディエッセ
  • レスチレン

第8章 ダーマルフィラー市場:用途別

  • 概要
  • フェイスライン矯正トリートメント
  • フェイスリフト
  • リップトリートメント

第9章 世界のダーマルフィラー市場:地域別

  • 概要
  • 米国
    • 北米
    • ラテンアメリカ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 日本
    • 中国
    • 韓国
    • インド
    • シンガポール
    • マレーシア
    • インドネシア
    • その他のアジア太平洋
  • 中東・アフリカ
    • 中東
    • アフリカ

第10章 競合情勢:世界のダーマルフィラー市場

  • 概要
  • 競合分析
  • 競合ダッシュボード
  • 競合ベンチマーキング
  • 世界のダーマルフィラー市場における主な成長戦略
  • 開発数における主要企業
  • 主な発展と成長戦略
    • 買収
    • 製品の承認と発売
    • 拡張
  • 主要企業の財務マトリックスと市場比率
    • 売上
    • 研究開発費

第11章 企業プロファイル

  • GALDERMA LABORATORIES, L.P.
  • ALLERGAN
  • MERZ PHARMA
  • DR. KORMAN LABORATORIES
  • SINCLAIR PHARMA
  • TEOXANE LABORATORIES
  • SUNEVA MEDICAL
  • SCIVISION BIOTECH INC.
  • MEDYTOX

第12章 付録

図表

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS 15
  • TABLE 2 NUMBER OF NON-SURGICAL PROCEDURES PERFORMED GLOBALLY INVOLVING HYALURONIC ACID 26
  • TABLE 3 PORTER'S FIVE FORCES ANALYSIS: GLOBAL DERMAL FILLERS MARKET 31
  • TABLE 4 GLOBAL DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 35
  • TABLE 5 GLOBAL DERMAL FILLERS MARKET, FOR HYALURONIC ACID, BY REGION 2018-2030 (USD MILLION) 36
  • TABLE 6 GLOBAL DERMAL FILLERS MARKET, FOR POLYMERS & PARTICLES, BY REGION, 2018-2030 (USD MILLION) 36
  • TABLE 7 GLOBAL DERMAL FILLERS MARKET, FOR CALCIUM HYDROXYLAPATITE, BY REGION 2018-2030 (USD MILLION) 37
  • TABLE 8 GLOBAL DERMAL FILLERS MARKET, FOR COLLAGEN, BY REGION 2018-2030 (USD MILLION) 37
  • TABLE 9 GLOBAL DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 38
  • TABLE 10 GLOBAL DERMAL FILLERS MARKET, FOR JUVEDERM, BY REGION 2018-2030 (USD MILLION) 39
  • TABLE 11 GLOBAL DERMAL FILLERS MARKET, FOR RADIESSE, BY REGION 2018-2030 (USD MILLION) 40
  • TABLE 12 GLOBAL DERMAL FILLERS MARKET, FOR RESTYLANE, BY REGION 2018-2030 (USD MILLION) 40
  • TABLE 13 GLOBAL DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 41
  • TABLE 14 GLOBAL DERMAL FILLERS MARKET, FOR FACIAL LINE CORRECTION TREATMENT, BY REGION 2018-2030 (USD MILLION) 42
  • TABLE 15 GLOBAL DERMAL FILLERS MARKET, FOR FACE-LIFT, BY REGION 2018-2030 (USD MILLION) 42
  • TABLE 16 GLOBAL DERMAL FILLERS MARKET, FOR LIP TREATMENTS, BY REGION 2018-2030 (USD MILLION) 43
  • TABLE 17 GLOBAL DERMAL FILLERS MARKET, BY REGION, 2018-2030 (USD MILLION) 44
  • TABLE 18 AMERICAS: DERMAL FILLERS MARKET, BY REGION, 2018-2030 (USD MILLION) 46
  • TABLE 19 AMERICAS: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 47
  • TABLE 20 AMERICAS: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 47
  • TABLE 21 AMERICAS: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 47
  • TABLE 22 NORTH AMERICA: DERMAL FILLERS MARKET, BY COUNTRY, 2018-2030 (USD MILLION) 48
  • TABLE 23 NORTH AMERICA: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 48
  • TABLE 24 NORTH AMERICA: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 49
  • TABLE 25 NORTH AMERICA: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 49
  • TABLE 26 US: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 49
  • TABLE 27 US: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 50
  • TABLE 28 US: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 50
  • TABLE 29 CANADA: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 50
  • TABLE 30 CANADA: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 51
  • TABLE 31 CANADA: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 51
  • TABLE 32 LATIN AMERICA: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 51
  • TABLE 33 LATIN AMERICA: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 52
  • TABLE 34 LATIN AMERICA: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 52
  • TABLE 35 EUROPE: DERMAL FILLERS MARKET, BY COUNTRY, 2018-2030 (USD MILLION) 53
  • TABLE 36 EUROPE: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 54
  • TABLE 37 EUROPE: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 54
  • TABLE 38 EUROPE: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 54
  • TABLE 39 GERMANY: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 55
  • TABLE 40 GERMANY: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 55
  • TABLE 41 GERMANY: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 55
  • TABLE 42 UK: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 56
  • TABLE 43 UK: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 56
  • TABLE 44 UK: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 56
  • TABLE 45 FRANCE: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 57
  • TABLE 46 FRANCE: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 57
  • TABLE 47 FRANCE: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 57
  • TABLE 48 ITALY: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 58
  • TABLE 49 ITALY: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 58
  • TABLE 50 ITALY: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 58
  • TABLE 51 SPAIN: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 59
  • TABLE 52 SPAIN: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 59
  • TABLE 53 SPAIN: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 59
  • TABLE 54 REST OF EUROPE: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 60
  • TABLE 55 REST OF EUROPE: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 60
  • TABLE 56 REST OF EUROPE: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 60
  • TABLE 57 ASIA-PACIFIC: DERMAL FILLERS MARKET, BY COUNTRY, 2018-2030 (USD MILLION) 61
  • TABLE 58 ASIA-PACIFIC: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 62
  • TABLE 59 ASIA-PACIFIC: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 62
  • TABLE 60 ASIA-PACIFIC: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 62
  • TABLE 61 JAPAN: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 63
  • TABLE 62 JAPAN: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 63
  • TABLE 63 JAPAN: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 63
  • TABLE 64 CHINA: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 64
  • TABLE 65 CHINA: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 64
  • TABLE 66 CHINA: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 64
  • TABLE 67 SOUTH KOREA: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 65
  • TABLE 68 SOUTH KOREA: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 65
  • TABLE 69 SOUTH KOREA: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 65
  • TABLE 70 INDIA: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 66
  • TABLE 71 INDIA: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 66
  • TABLE 72 INDIA: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 66
  • TABLE 73 SINGAPORE: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 67
  • TABLE 74 SINGAPORE: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 67
  • TABLE 75 SINGAPORE: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 67
  • TABLE 76 MALAYSIA: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 68
  • TABLE 77 MALAYSIA: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 68
  • TABLE 78 MALAYSIA: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 68
  • TABLE 79 INDONESIA: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 69
  • TABLE 80 INDONESIA: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 69
  • TABLE 81 INDONESIA: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 69
  • TABLE 82 REST OF ASIA-PACIFIC: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 70
  • TABLE 83 REST OF ASIA-PACIFIC: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 70
  • TABLE 84 REST OF ASIA-PACIFIC: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 71
  • TABLE 85 MIDDLE EAST AND AFRICA: DERMAL FILLERS MARKET, BY COUNTRY, 2018-2030 (USD MILLION) 71
  • TABLE 86 MIDDLE EAST AND AFRICA: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 72
  • TABLE 87 MIDDLE EAST AND AFRICA: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 72
  • TABLE 88 MIDDLE EAST AND AFRICA: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 73
  • TABLE 89 MIDDLE EAST: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 73
  • TABLE 90 MIDDLE EAST: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 73
  • TABLE 91 MIDDLE EAST: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 74
  • TABLE 92 AFRICA: DERMAL FILLERS MARKET, BY TYPE, 2018-2030 (USD MILLION) 74
  • TABLE 93 AFRICA: DERMAL FILLERS MARKET, BY BRAND, 2018-2030 (USD MILLION) 74
  • TABLE 94 AFRICA: DERMAL FILLERS MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 75
  • TABLE 95 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE DERMAL FILLERS MARKET 79
  • TABLE 96 ACQUISITION: GLOBAL DERMAL FILLERS MARKET 80
  • TABLE 97 PRODUCT APPROVAL AND LAUNCH: GLOBAL DERMAL FILLERS MARKET 80
  • TABLE 98 EXPANSION: GLOBAL DERMAL FILLERS MARKET 81
  • TABLE 99 GALDERMA LABORATORIES, LP: PRODUCTS/SERVICES OFFERED 83
  • TABLE 100 ALLERGAN: PRODUCTS/SERVICES OFFERED 86
  • TABLE 101 KEY DEVELOPMENTS 86
  • TABLE 102 MERZ PHARMA: PRODUCTS/SERVICES OFFERED 89
  • TABLE 103 MERZ PHARMA: KEY DEVELOPMENTS 89
  • TABLE 104 DR. KORMAN LABORATORIES: PRODUCTS/SERVICES OFFERED 91
  • TABLE 105 SINCLAIR PHARMA: PRODUCTS/SERVICES OFFERED 94
  • TABLE 106 SINCLAIR PHARMA: KEY DEVELOPMENTS 94
  • TABLE 107 TEOXANE LABORATORIES: PRODUCTS/SERVICES OFFERED 96
  • TABLE 108 SUNEVA MEDICAL: PRODUCTS/SERVICES OFFERED 98
  • TABLE 109 SCIVISION BIOTECH INC.: PRODUCTS/SERVICES OFFERED 100
  • TABLE 110 MEDYTOX: PRODUCTS/SERVICES OFFERED 102

LIST OF FIGURES

  • FIGURE 1 GLOBAL DERMAL FILLERS MARKET STRUCTURE 16
  • FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 22
  • FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL DERMAL FILLERS MARKET 25
  • FIGURE 4 COMPARISON BETWEEN FEES INCURRED BY PHYSICIANS FOR DERMAL FILLERS AND SURGERY IN THE US (2018) 27
  • FIGURE 5 DRIVERS IMPACT ANALYSIS 28
  • FIGURE 6 RESTRAINTS IMPACT ANALYSIS 29
  • FIGURE 7 VALUE CHAIN: GLOBAL DERMAL FILLERS MARKET 33
  • FIGURE 8 GLOBAL DERMAL FILLERS MARKET, BY TYPE, 2018 & 2030 (USD MILLION) 35
  • FIGURE 9 GLOBAL DERMAL FILLERS MARKET, BY BRAND, 2018 & 2030 (USD MILLION) 38
  • FIGURE 10 GLOBAL DERMAL FILLERS MARKET, BY APPLICATION, 2018 & 2030 (USD MILLION) 41
  • FIGURE 11 GLOBAL DERMAL FILLERS MARKET, BY REGION, 2018 & 2030 (USD MILLION) 45
  • FIGURE 12 AMERICAS: DERMAL FILLERS MARKET, BY REGION, 2018 (%) 46
  • FIGURE 13 NORTH AMERICA: DERMAL FILLERS MARKET, BY COUNTRY, 2018 (%) 48
  • FIGURE 14 EUROPE: DERMAL FILLERS MARKET, BY COUNTRY, 2018 (%) 53
  • FIGURE 15 ASIA-PACIFIC: DERMAL FILLERS MARKET, BY COUNTRY, 2018 (%) 61
  • FIGURE 16 MIDDLE EAST AND AFRICA: DERMAL FILLERS MARKET, BY COUNTRY, 2018 (%) 72
  • FIGURE 17 DERMAL FILLERS MARKET, MARKET SHARE ANALYSIS (%) 76
  • FIGURE 18 COMPETITOR DASHBOARD: GLOBAL DERMAL FILLERS MARKET 77
  • FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS 78
  • FIGURE 21 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN GLOBAL DERMAL FILLERS MARKET 79
  • FIGURE 22 DERMAL FILLERS MARKET, KEY DEVELOPMENT ANALYSIS (% SHARE) 80
  • FIGURE 23 SALES, 2018 82
  • FIGURE 24 MAJOR PLAYERS R&D EXPENDITURE 2018 82
  • FIGURE 25 GALDERMA LABORATORIES, L.P.: SWOT ANALYSIS 84
  • FIGURE 26 ALLERGAN: FINANCIAL OVERVIEW SNAPSHOT 85
  • FIGURE 27 ALLERGAN: SWOT ANALYSIS 87
  • FIGURE 28 MERZ PHARMA: FINANCIAL OVERVIEW SNAPSHOT 88
  • FIGURE 29 MERZ PHARMA: SWOT ANALYSIS 90
  • FIGURE 30 DR. KORMAN LABORATORIES: SWOT ANALYSIS 92
  • FIGURE 31 SINCLAIR PHARMA: FINANCIAL OVERVIEW SNAPSHOT 93
  • FIGURE 32 SINCLAIR PHARMA: SWOT ANALYSIS 94
  • FIGURE 33 TEOXANE LABORATORIES: SWOT ANALYSIS 97
  • FIGURE 34 SUNEVA MEDICAL: SWOT ANALYSIS 99
  • FIGURE 35 SCIVISION BIOTECH INC.: SWOT ANALYSIS 101
  • FIGURE 36 MEDYTOX: SWOT ANALYSIS 103
目次
Product Code: MRFR/Pharma/2606-CR

Market Overview

According to MRFR's study of the dermal filler market, the rising popularity of cosmetic surgery is anticipated to be a key driver of market growth throughout the forecast period. It is projected that during the assessment period, the rising popularity of facial operations among both men and women will have a significant impact on market growth. In addition, main players' ongoing technical advancement in dermal fillers is anticipated to be advantageous for the sector in the coming years. Over the time of the investigation, the market has benefited significantly from the rising demand for minimally invasive procedures. To match the growing demand, manufacturers are releasing a variety of cutting-edge products, which is expected to spur growth in the ensuing period.

Segment Overview

The Global Dermal Fillers market consists of three main types of segment insights: Type, Application, and Brand.

Hyaluronic acid is anticipated to experience the highest CAGR of any form of dermal filler throughout the projection period.

The lip treatment and facial line correcting treatment segments are estimated to generate strong market worth during the forecast timeframe in the application section of a global dermal fillers market.

The Americas is anticipated to gain the biggest market share throughout the analysis period, according to MRFR's report on the dermal fillers market.

Regional Analysis

The Americas is anticipated to gain the biggest market share throughout the analysis period, according to MRFR's report on the dermal fillers market. The rising necessity for minimally invasive facial surgeries and the rising demand for cosmetic items both contribute to the regional market's expansion. Also, the expanding number of clinical studies for cutting-edge skin beauty products is projected to further stimulate the local market. The US is expected to contribute significantly to the growth of the regional market among all the countries in the region.

Over the projected period, Europe is anticipated to hold the second-largest market share for dermal fillers. The region's market is expected to be significantly influenced by the rising popularity of minimally-invasive methods of face enhancement in the ensuing years. Another significant factor that is anticipated to boost the sales of cosmetic procedures in the region is the rising number of product licenses and product access throughout the region.

Major Players

Suneva Medical (US), Sinclair Pharma (UK), Medytox (South Korea), Merz Pharma (Germany), SciVision Biotech Inc. (Taiwan), Galderma Laboratories, LP (Switzerland), Allergan (Ireland), Dr. Korman Laboratories (Israel), and Teoxane Laboratories (Switzerland) are a few of the companies that work for the Global Dermal Fillers.

COVID 19 Impacts

The research by MRFR predicts that the coronavirus outbreak will have a detrimental effect on the world market. In 2018, the market is probably going to have a 40% decline from 2019. The lockdown that was imposed on a global front resulted in the closure of numerous cosmetic facilities and clinics. The number of cosmetic procedures is declining due to the rising incidence of coronavirus, which has a detrimental effect on the size of the dermal fillers industry. Dermal fillers are frequently utilised in procedures that are minimally invasive as a facial firmness and wrinkle-reduction anti-aging treatment. Several types of products are used with dermal fillers to improve the look of scars, eliminate wrinkles, soften face creases, and enhance shallow contours. Dermal fillers are becoming more widely accepted among people of all ages as awareness of the advantages they have over surgical procedures grows. The global market for dermal fillers is being impacted by the corona virus pandemic. the COVID-19 corona virus illness outbreak in 2018. As of right today, it has killed 281,736 individuals and impacted more over 4 million people worldwide.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW 13
    • 1.1.1 MARKET SYPNOSIS 14

2 MARKET INTRODUCTION

  • 2.1 SCOPE OF THE STUDY 15
  • 2.2 RESEARCH OBJECTIVE 15
  • 2.3 LIST OF ASSUMPTIONS 15

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW 17
  • 3.2 DATA MINING 17
  • 3.3 SECONDARY RESEARCH 18
  • 3.4 PRIMARY RESEARCH 19
    • 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 19
    • 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 20
  • 3.5 FORECASTING TECHNIQUES 20
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21
    • 3.6.1 BOTTOM-UP APPROACH 22
    • 3.6.2 TOP-DOWN APPROACH 23
  • 3.7 DATA TRIANGULATION 24
  • 3.8 VALIDATION 24

4 MARKET DYNAMICS

  • 4.1 OVERVIEW 25
  • 4.2 DRIVERS 26
    • 4.2.1 GROWING DEMAND FOR FACIAL AESTHETICS GLOBALLY 26
    • 4.2.2 INCREASING NUMBER OF AESTHETIC PROCEDURES PERFORMED BY PLASTIC SURGEONS 26
    • 4.2.3 COST-EFFECTIVE ALTERNATIVE TO COSMETIC SURGERIES 26
    • 4.2.4 RESTRAINTS 28
    • 4.2.5 SIDE-EFFECTS ASSOCIATED WITH DERMAL FILLERS 28
    • 4.2.6 BLACK MARKET OF DERMAL FILLERS AND EFFECTS OF UNREGISTERED PRACTITIONERS 29
  • 4.3 OPPORTUNITIES 30
    • 4.3.1 INCREASING NUMBER OF CLINICAL TRIAL STUDIES 30
    • 4.3.2 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 30

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTERS FIVE FORCES 31
    • 5.1.1 THREAT OF NEW ENTRANTS 32
    • 5.1.2 BARGAINING POWER OF SUPPLIERS 32
    • 5.1.3 THREAT OF SUBSTITUTES 32
    • 5.1.4 BARGAINING POWER OF BUYERS 32
    • 5.1.5 INTENSITY OF RIVALRY 32
  • 5.2 VALUE CHAIN ANALYSIS 33
    • 5.2.1 RESEARCH AND DEVELOPMENT 34
    • 5.2.2 MANUFACTURING PROCESS OF AESTHETIC PRODUCTS 34
    • 5.2.3 MARKETING AND DISTRIBUTION 34

6 DERMAL FILLERS MARKET, BY TYPE

  • 6.1 OVERVIEW 35
  • 6.2 HYALURONIC ACID 36
  • 6.3 POLYMERS & PARTICLES 36
  • 6.4 CALCIUM HYDROXYLAPATITE 37
  • 6.5 COLLAGEN 37

7 DERMAL FILLERS MARKET, BY BRAND

  • 7.1 OVERVIEW 38
  • 7.2 JUVEDERM 39
  • 7.3 RADIESSE 39
  • 7.4 RESTYLANE 40

8 DERMAL FILLERS MARKET, BY APPLICATION

  • 8.1 OVERVIEW 41
  • 8.2 FACIAL LINE CORRECTION TREATMENT 42
  • 8.3 FACE-LIFT 42
  • 8.4 LIP TREATMENTS 43

9 GLOBAL DERMAL FILLERS MARKET, BY REGION

  • 9.1 OVERVIEW 44
  • 9.2 AMERICAS 46

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.2.1 NORTH AMERICA 48

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

      • 9.2.1.1 US 49

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

      • 9.2.1.2 CANADA 50

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.2.2 LATIN AMERICA 51

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

  • 9.3 EUROPE 53

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.3.1 GERMANY 55

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.3.2 UK 56

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.3.3 FRANCE 57

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.3.4 ITALY 58

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.3.5 SPAIN 59

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.3.6 REST OF EUROPE 60

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

  • 9.4 ASIA-PACIFIC 61

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.4.1 JAPAN 63

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.4.2 CHINA 64

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.4.3 SOUTH KOREA 65

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.4.4 INDIA 66

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.4.5 SINGAPORE 67

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.4.6 MALAYSIA 68

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.4.7 INDONESIA 69

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.4.8 REST OF ASIA-PACIFIC 70

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

  • 9.5 MIDDLE EAST AND AFRICA 71

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.5.1 MIDDLE EAST 73

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

    • 9.5.2 AFRICA 74

DERMAL FILLERS MARKET, BY TYPE

DERMAL FILLERS MARKET, BY BRAND

DERMAL FILLERS MARKET, BY APPLICATION

10 COMPETITIVE LANDSCAPE: GLOBAL DERMAL FILLERS MARKET

  • 10.1 OVERVIEW 76
  • 10.2 COMPETITIVE ANALYSIS 76
  • 10.3 COMPETITOR DASHBOARD 77
  • 10.4 COMPETITIVE BENCHMARKING 78
  • 10.5 MAJOR GROWTH STRATEGY IN THE GLOBAL DERMAL FILLERS MARKET 79
  • 10.6 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 79
  • 10.7 KEY DEVELOPMENTS AND GROWTH STRATEGIES 80
    • 10.7.1 ACQUISITION 80
    • 10.7.2 PRODUCT APPROVAL AND LAUNCH 80
    • 10.7.3 EXPANSION 81
  • 10.8 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 82
    • 10.8.1 SALES 82
    • 10.8.2 R&D EXPENDITURE 82

11 COMPANY PROFILES

  • 11.1 GALDERMA LABORATORIES, L.P. 83
    • 11.1.1 COMPANY OVERVIEW 83
    • 11.1.2 FINANCIAL OVERVIEW 83
    • 11.1.3 PRODUCTS/SERVICES OFFERED 83
    • 11.1.4 KEY DEVELOPMENTS 83
    • 11.1.5 SWOT ANALYSIS 84
    • 11.1.6 KEY STRATEGIES 84
  • 11.2 ALLERGAN 85
    • 11.2.1 COMPANY OVERVIEW 85
    • 11.2.2 FINANCIAL OVERVIEW 85
    • 11.2.3 PRODUCTS/SERVICES OFFERED 86
    • 11.2.4 ALLERGAN: KEY DEVELOPMENTS 86
    • 11.2.5 SWOT ANALYSIS 87
    • 11.2.6 KEY STRATEGIES 87
  • 11.3 MERZ PHARMA 88
    • 11.3.1 COMPANY OVERVIEW 88
    • 11.3.2 FINANCIAL OVERVIEW 88
    • 11.3.3 PRODUCTS/SERVICES OFFERED 89
    • 11.3.4 KEY DEVELOPMENTS 89
    • 11.3.5 SWOT ANALYSIS 90
    • 11.3.6 KEY STRATEGIES 90
  • 11.4 DR. KORMAN LABORATORIES 91
    • 11.4.1 COMPANY OVERVIEW 91
    • 11.4.2 FINANCIAL OVERVIEW 91
    • 11.4.3 PRODUCTS/SERVICES OFFERED 91
    • 11.4.4 KEY DEVELOPMENTS 91
    • 11.4.5 SWOT ANALYSIS 92
    • 11.4.6 KEY STRATEGIES 92
  • 11.5 SINCLAIR PHARMA 93
    • 11.5.1 COMPANY OVERVIEW 93
    • 11.5.2 FINANCIAL OVERVIEW 93
    • 11.5.3 PRODUCTS/SERVICES OFFERED 94
    • 11.5.4 KEY DEVELOPMENTS 94
    • 11.5.5 SWOT ANALYSIS 94
    • 11.5.6 KEY STRATEGIES 95
  • 11.6 TEOXANE LABORATORIES 96
    • 11.6.1 COMPANY OVERVIEW 96
    • 11.6.2 FINANCIAL OVERVIEW 96
    • 11.6.3 PRODUCTS/SERVICES OFFERED 96
    • 11.6.4 KEY DEVELOPMENTS 97
    • 11.6.5 SWOT ANALYSIS 97
    • 11.6.6 KEY STRATEGIES 97
  • 11.7 SUNEVA MEDICAL 98
    • 11.7.1 COMPANY OVERVIEW 98
    • 11.7.2 FINANCIAL OVERVIEW 98
    • 11.7.3 PRODUCTS/SERVICES OFFERED 98
    • 11.7.4 KEY DEVELOPMENTS 98
    • 11.7.5 SWOT ANALYSIS 99
    • 11.7.6 KEY STRATEGIES 99
  • 11.8 SCIVISION BIOTECH INC. 100
    • 11.8.1 COMPANY OVERVIEW 100
    • 11.8.2 FINANCIAL OVERVIEW 100
    • 11.8.3 PRODUCTS/SERVICES OFFERED 100
    • 11.8.4 KEY DEVELOPMENTS 100
    • 11.8.5 SWOT ANALYSIS 101
    • 11.8.6 KEY STRATEGIES 101
  • 11.9 MEDYTOX 102
    • 11.9.1 COMPANY OVERVIEW 102
    • 11.9.2 FINANCIAL OVERVIEW 102
    • 11.9.3 PRODUCTS/SERVICES OFFERED 102
    • 11.9.4 KEY DEVELOPMENTS 102
    • 11.9.5 SWOT ANALYSIS 103
    • 11.9.6 KEY STRATEGIES 103

12 APPENDIX

  • 12.1 REFERENCES 104
  • 12.2 RELATED REPORTS 104